We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.65B
1-Year Est. Return
18.1%
This Fund
S&P 500
This Quarter
Est. Return
-11.29%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$804M
AUM Growth
-$144M
(-15%)
Cap. Flow
-$27.2M
Cap. Flow
% of AUM
-3.38%
Top 10 Holdings %
Top 10 Hldgs %
21.56%
Holding
272
New
8
Increased
53
Reduced
127
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$7.85M |
| 2 |
RTN
Raytheon Company
RTN
|
+$1.79M |
| 3 |
Visa
V
|
+$1.77M |
| 4 |
Amazon
AMZN
|
+$1.65M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$820K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$8M |
| 2 |
TE Connectivity
TEL
|
+$2.36M |
| 3 |
CVS Health
CVS
|
+$1.78M |
| 4 |
SLB Ltd
SLB
|
+$1.66M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.54% |
| 2 | Technology | 15.29% |
| 3 | Miscellaneous | 13.75% |
| 4 | Industrials | 10.97% |
| 5 | Financials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ExxonMobil
XOM
$696B
| $9.36M | 1.16% |
137,215
-6,294
| -4% | -$494K |
|
27
Dollar Tree
DLTR
$21.2B
| $8.82M | 1.1% |
97,607
-1,561
| -2% | -$132K |
|
28
Alphabet (Google) Class C
GOOG
$4.18T
| $8.78M | 1.09% |
169,620
+1,440
| +0.9% | +$77.1K |
|
29
Middleby
MIDD
$5.02B
| $8.63M | 1.07% |
83,988
-578
| -0.7% | -$65.8K |
|
30
Roper Technologies
ROP
$38B
| $8.4M | 1.04% |
31,506
+404
| +1% | +$114K |
|
31
PepsiCo
PEP
$185B
| $8.37M | 1.04% |
75,735
-1,195
| -2% | -$135K |
|
32
Stryker
SYK
$108B
| $8.18M | 1.02% |
52,169
-790
| -1% | -$132K |
|
33
NextEra Energy
NEE
$169B
| $7.95M | 0.99% |
182,860
-9,568
| -5% | -$418K |
|
34
Aflac
AFL
$58.9B
| $7.92M | 0.98% |
173,789
-876
| -0.5% | -$38.9K |
|
35
Merck
MRK
$355B
| $7.8M | 0.97% |
106,939
-5,531
| -5% | -$390K |
|
|
36
TE Connectivity
TEL
$58.3B
| $7.77M | 0.97% |
102,749
-30,661
| -23% | -$2.36M |
|
|
37
Linde
LIN
$213B
| $7.75M | 0.96% |
+49,673
| New | +$7.85M |
|
38
Abbott
ABT
$177B
| $7.74M | 0.96% |
107,039
-4,323
| -4% | -$304K |
|
39
General Mills
GIS
$19.6B
| $7.53M | 0.94% |
193,475
-3,122
| -2% | -$132K |
|
|
RTN
40
DELISTED
Raytheon Company
RTN
| $7.33M | 0.91% |
47,770
+9,986
| +26% | +$1.79M |
|
|
41
Thermo Fisher Scientific
TMO
$237B
| $7.07M | 0.88% |
31,589
+3,495
| +12% | +$820K |
|
42
AbbVie
ABBV
$465B
| $7.04M | 0.87% |
76,329
-9,190
| -11% | -$808K |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $6.94M | 0.86% |
108,310
-8,303
| -7% | -$613K |
|
44
Gilead Sciences
GILD
$181B
| $6.81M | 0.85% |
108,804
-1,216
| -1% | -$85K |
|
45
McDonald's
MCD
$179B
| $6.8M | 0.85% |
38,288
-740
| -2% | -$131K |
|
46
Invesco QQQ Trust
QQQ
$474B
| $6.43M | 0.8% |
41,677
-416
| -1% | -$69.6K |
|
47
3M
MMM
$84.9B
| $6.43M | 0.8% |
40,348
-1,421
| -3% | -$236K |
|
|
48
CVS Health
CVS
$121B
| $6.05M | 0.75% |
92,327
-23,822
| -21% | -$1.78M |
|
49
Danaher
DHR
$147B
| $5.71M | 0.71% |
62,508
-305
| -0.5% | -$27.7K |
|
50
Pfizer
PFE
$157B
| $4.92M | 0.61% |
118,689
-1,446
| -1% | -$60K |
|
Similar funds
MCIL
BCM
SOS
GS
NPA
AAM
OHIF
SCM
Boston Family Office's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Family Office held 272 positions worth $804M, down 15% from $949M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Boston Family Office withdrew a net $27.2M in Q4 2018, closing 24 positions and reducing 127 holdings. Its most notable exit was Praxair Inc, an estimated $8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Boston Family Office opened a new position in Linde worth $7.75M.
- Boston Family Office's largest Q4 2018 buy was Linde: 49,673 shares worth $7.75M.
- Boston Family Office added most to Raytheon Company in Q4 2018, an estimated $1.79M increase.
- Boston Family Office's biggest Q4 2018 reduction was TE Connectivity, cutting an estimated $2.36M.
- Boston Family Office fully exited Praxair Inc in Q4 2018, selling an estimated $8M.
- Boston Family Office's ten largest holdings make up 22% of its $804M portfolio in Q4 2018.
- Boston Family Office opened 8 new positions and closed 24 in Q4 2018.
- Boston Family Office's portfolio value fell 15% quarter-over-quarter to $804M.
Based on Boston Family Office's 13F filing for Q4 2018, filed 12 Feb 2019.